MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2026 International Congress

    Environmental Risk Factor Co-Exposure as Drivers of Parkinson’s Disease Development: A Scoping Review

    A. Mcnamara, K. Daminato, L. Collins-Praino (Adelaide, Australia)

    Objective: To map and synthesise epidemiological evidence assessing environmental co-exposures and Parkinson’s disease (PD) risk Background: PD is a multifactorial neurodegenerative disorder attributed to genetic,…
  • 2026 International Congress

    Distinct Local and Global Functional Network Reorganization Underlying STN versus GPi DBS in Parkinson’s Disease

    H. Ding, K. Xie, B. Bahners, W. He, J. Chen, M. Metzger, B. Nasseroleslami, J. Volkmann, D. Li, M. Muthuraman, C. Zhang (Würzburg, Germany)

    Objective: To identify target-specific neuroimaging biomarkers for STN and GPi DBS and evaluate their impact on the global functional hierarchy and clinical outcomes. Background: Selection…
  • 2026 International Congress

    Quantitative Susceptibility Mapping Revealed Regional Iron Alteration and As a Biomarker for Dopaminergic Deficits in Parkinson’s Disease

    XY. Xie, HL. Wang, YL. Du, G. Wang (Shanghai, China)

    Objective: This study aimed to identify regions with altered brain iron accumulation using quantitative susceptibility mapping (QSM) and to investigate the association between iron deposition…
  • 2026 International Congress

    LRRK2 in Focus: A Global Browser Linking Genetic Diversity to Functional Effects

    S. Grant, V. van Midden, E. Fernandez, M. Cham, E. Sammler, D. Alessi, H. Morris, C. Blauwendraat, A. Singleton, L. Lange (Bethesda MD, USA)

    Objective: To develop a publicly accessible web browser that allows users to easily explore the distribution of LRRK2 variants in both Parkinson’s disease (PD) and…
  • 2026 International Congress

    Voice-Based Screening of Parkinsonian Disorders Using Acoustic Feature Analysis and Machine Learning

    L. Cruz-Mondragon, A. Shih, V. Santini, S. Panchawagh (Winston Salem, USA)

    Objective: To evaluate whether acoustic features from voice recordings can distinguish Parkinson’s disease and related parkinsonian disorders from healthy controls. Background: Speech production depends on…
  • 2026 International Congress

    Clinical Underestimation of Wearing-Off in Parkinson’s Disease: Patient-Reported Outcomes Versus Clinical Assessment and Impact on Quality of Life

    M. Acharya, A. Debnath (Kharagpur, India)

    Objective: To prospectively investigate the frequency and determinants of wearing-off (WO) in Parkinson's disease (PD) using a validated patient-reported instrument compared to routine neurological evaluation,…
  • 2026 International Congress

    Occupational Pesticide Exposure, Personal Protective Equipment, and Parkinson’s Disease: An Observational Study from the PPMI Cohort

    B. Gonzalez-Bedolla, F. Luna-Rangel, S. Robles-Bernal, E. Santiago-Delacruz, D. Rebolledo-Garcia (Monterrey, Mexico)

    Objective: To evaluate the association between occupational exposure to specific pesticides and Parkinson’s disease in participants from the PPMI Online cohort, and to determine whether…
  • 2026 International Congress

    Beyond Motor Symptoms: Utilizing the FreeSurfer Brainstem Substructures Module to Characterize a Complex Parkinsonian Phenotype with Profound Dysautonomia

    M L. Chin, A K. Lee (Ipoh, Malaysia)

    Objective: To describe the autonomic function profile and quantitative brainstem substructures analysis in a 62-year-old male of Parkinsonism complicated by severe autonomic failure and neuropsychiatric…
  • 2026 International Congress

    Genome-wide Discovery of GBA1 Modifiers in Parkinsons Disease Carriers across Populations from the Global Parkinsons Genetics Program

    M. Makarious, L. Lange, Z. Fang, A. Singleton, C. Blauwendraat, H. Leonard (Washington, USA)

    Objective: To identify genetic risk modifiers for GBA1 risk variant carriers of European and African ancestry, we used  data from GP2 (http://gp2.org/), the UK Biobank,…
  • 2026 International Congress

    Bridging Genetics and Precision Medicine in Parkinson’s Disease through GP2: Translating Genetic Risk into Trial-Eligible GBA1 and LRRK2 Cohorts

    L. Lange, K. Atterling Brolin, E. Navarro-Jones, M. Tan, S. Meyer, D. Vitale, A. Singleton, C. Blauwendraat, M. Nalls, A. Noyce, H. Morris (Bethesda, USA)

    Objective: To advance precision medicine in Parkinson’s disease (PD) by integrating large-scale clinico-genetic data from diverse populations worldwide and establishing a framework to characterize individuals…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley